404 Page not found

Sort by

It appears the page you were searching for can't be found. Try using the search box below to find what you were looking for.

56 Results

Search results

    PATH is designed to help users combine and use clinical and genomic information to stratify patients as part of efforts to develop more tailored therapies.

    NEW YORK (GenomeWeb News) – In the latter half of 2013, Bio-Rad Laboratories accrued $35 million in costs associated with its initial efforts to resolve investigations into violations of federal anti-bribery laws, the company said in its Form 10-K this week.

    There is growing interest among forensics researchers in expanding the use of molecular technologies, such as arrays and next-generation sequencing, to advance the field. But there are challenges, as forensics, particularly in its application to criminal cases, has been slow to adopt new technologies.

    As an indication that next-generation sequencing is making its way into in vitro diagnostics, Illumina said this week that it has applied Europe's CE mark to the MiSeqDx Cystic Fibrosis System, a diagnostic version of its MiSeq sequencer with two associated cystic fibros

    Affymetrix said this week that it has signed an agreement with South Korea's DNA Link granting that company a worldwide license to develop and commercialize a forensic test for comprehensive human identification and other diagnostic tests using Affymetrix's micro

    DxTerity Diagnostics has developed a rapid assay for analyzing gene expression of as many as 100 genes directly from small amounts of formalin-fixed, paraffin-embedded clinical samples without prior RNA extraction.

    IP Roundup: Intel, SIRS-Lab, Illumina, Inserm, Affymetrix, BU, USC, Fluidigm, and More

    Premium
    Article: In-Depth—in Microarrays & Multiplexing

    Intel of Santa Clara, Calif., has received US Patent No.

    Product Watch: Akonni TruTip and Illumina TruSeq Sample Prep Kits

    Premium
    Article: In-Depth—in PCR

    Akonni Biosystems this week introduced a new family of TruTip extraction products for rapidly purifying human genomic DNA on the Hamilton Microlab STAR line of robotic liquid handlers.

    IP Update: Population Genetics Technologies; Ohio State University; Maxwell Sensors; and More

    Premium
    Article: In-Depth—in Microarrays & Multiplexing

    Population Genetics Technologies of Cambridge, UK, has received US Patent No.

    Funding Update: Recent NSF Microarray Grants

    Premium
    Article: In-Depth—in Microarrays & Multiplexing

    NSF Microarray Grants Awarded July 20, 2011 — Nov. 8, 2011

    Illumina President and CEO Jay Flatley said this week that the company has installed nearly 1,000 of its Eco real-time PCR systems since it launched the platform in July 2010 after acquiring biotech firm Helixis.

    IP Roundup

    Premium
    Article: In-Depth—in Microarrays & Multiplexing

    The California Institute of Technology of Pasadena has received US Patent No.

    IP Roundup

    Premium
    Article: In-Depth—in Microarrays & Multiplexing

    Advanced Liquid Logic, Duke University, NuGen Technologies, Stanford University, Schott, Corning, Immucor

    RainDance Launches Targeted FFPE Sequencing Products; Partners with NuGen on Sample Prep

    Premium
    Article: In-Depth—in Clinical Sequencing

    The new product, called the DeepSeq FFPE Solution, runs on the company's RDT 1000 microdroplet PCR instrument and allows researchers to discover rare mutations.

    Product Watch

    Premium
    Article: In-Depth—in PCR

    RainDance's DeepSeq FFPE solution, Akonni Biosystems' TruSentry system; and New England Biolabs' NEBNext Small RNA Sample Prep Set 1 and 3.

    IP Roundup

    Premium
    Article: In-Depth—in Microarrays & Multiplexing

    Joseph Huang, Yong Shi, Yufeng Ma, Oncotherapy Science, Life Technologies, Affymetrix, Illumina

    FDA Official Offers Agency's Take on Protein IVDMIA Mock 510(k) Submissions

    Premium
    Article: In-Depth—in Proteomics & Protein Research

    Attention to assay reproducibility and selection of appropriate intended use populations will be key to the success of proteomics-based tests, FDA staff fellow Joshua Levin suggested at a talk this week discussing the agency's review of two mock submissions for protein IVDMIAs.

    NanoString is betting that its test will predict treatment benefit for specific classes of chemotherapies, which will differentiate it from other genomic breast cancer tests on the market.

    Downloads and Upgrades

    Premium
    Article: In-Depth—in Informatics

    GenomeQuest, AVT 2.0, caBIG Life Sciences Domain Analysis Model 2.0, LabKey Server 10.3, Knowledge Explorer version 3.3, Biomarkers Consortium, iRefWeb and iRefIndex, Qlucore Omics Explorer 2.2, PDB, MSigDB 3.0.

    Product Watch

    Premium
    Article: In-Depth—in PCR

    Qiagen's FFPE kits, NuGen's Ovation FFPE kits, NanoString's nCounter Copy Number Variation CodeSets, Illumina's TruSeq sample-prep kits, the Agilent SureSelect XT Target Enrichment System

Pages

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.